Insider · CIK 0001778501
Peter Wijngaard
Files at HEPA (Hepion Pharmaceuticals, Inc.). First filing Nov 28, 2023, latest Nov 28, 2023.
In brief
Peter Wijngaard files SEC Form 4 as director at HEPA (Hepion Pharmaceuticals, Inc.). Since Nov 28, 2023, Peter Wijngaard has reported 1 open-market buy worth $15k and 0 open-market sells worth $0, the latest filed on Nov 28, 2023.
A track record needs three past buys with six months of prices behind them; Peter Wijngaard has 1, so none is measured yet.
The newest scored trade: bought $15k of HEPA on Nov 24, 2023, filed Nov 28, 2023, scored 33 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HEPA: Hepion Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | HEPAbuy Hepion Pharmaceuticals, Inc. | $15k 5,000 shares | +111% | +11% from low-85% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 24, 2023 | HEPA Hepion Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +2,500 | $3.09 | $7,725 | 7,001 | Nov 28, 2023 |
| Nov 27, 2023 | HEPA Hepion Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +2,500 | $3.05 | $7,625 | 9,501 | Nov 28, 2023 |
Questions about Peter Wijngaard
Answered from the filings on this page, as of the latest one.
Is Peter Wijngaard buying or selling?
Not in the last 12 months. Peter Wijngaard's latest open-market trade on SEC Form 4 was bought $15k of HEPA on Nov 24, 2023.
How did Peter Wijngaard's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Wijngaard has 1.
Where does Peter Wijngaard file Form 4?
Peter Wijngaard has filed Form 4 at HEPA (Hepion Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.